New patent for the drug Astrazeneca KOSELUGO – DrugPatentWatch
Annual Drug Patent Expiration for KOSELUGO
Koselugo is a drug marketed by Astrazeneca and included in one NDA. It is available from a single supplier. There are four patents protecting this drug.
This drug has one hundred and forty-two patent family members in thirty-nine countries.
The generic ingredient in KOSELUGO is selumetinib sulfate. One registered supplier for this compound. Additional details are available on the selumetinib sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Astrazeneca KOSELUGO